Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context.

ABSTRACT:

Background

Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals. This substitution often occurs without physician oversight, raising patient safety concerns. We aimed to characterize substitution and doctor-patient communication patterns in Canada, where there is a mature market and national regulatory system for medical cannabis.

Methods

We conducted an anonymous, cross-sectional online survey in May 2021 for seven days with adult Canadian federally-authorized medical cannabis patients (N = 2697) registered with two global cannabis companies to evaluate patient perceptions of Primary Care Provider (PCP) knowledge of medical cannabis and communication regarding medical cannabis with PCPs, including PCP aut

SUBMITTER: Holman A 

PROVIDER: S-EPMC9195481 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature